First recanalization of a coronary artery chronic total obstruction in an 11-year-old child with kawasaki disease sequelae using the CROSSER catheter

Pediatric Cardiology

Volumn 28, Issue 5, 2007, Pages 389-393

  Dahdah, N ^a   Ibrahim, R ^b   Cannon, L ^c  

^a UNIVERSITY OF MONTREAL   (Canada)

^b MONTREAL HEART INSTITUTE   (Canada)

^c Northern Michigan Hospital   (United States)

Author keywords

Catheter intervention; Chronic total occlusion; Coronary aneurysm; Coronary calcification; Kawasaki disease

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; BISOPROLOL; CLOPIDOGREL; IMMUNOGLOBULIN; WARFARIN;

ADD ON THERAPY; ANAMNESIS; ARTERY CALCIFICATION; ARTICLE; CASE REPORT; CORONARY ARTERY ANEURYSM; CORONARY ARTERY OBSTRUCTION; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART CATHETER; HUMAN; MUCOCUTANEOUS LYMPH NODE SYNDROME; RECANALIZATION; SCHOOL CHILD; SURGICAL TECHNIQUE;

BALLOON DILATATION; CALCINOSIS; CATHETERIZATION; CHILD; COLLATERAL CIRCULATION; CORONARY ANEURYSM; CORONARY ANGIOGRAPHY; EQUIPMENT DESIGN; FEMALE; HEART CATHETERIZATION; HUMANS; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYOCARDIAL REVASCULARIZATION; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 34548694787     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-006-0083-3     Document Type: Article

References (17)

1. Akaji T, Ogawa S, Ino T, et al. (2000) Catheter interventional treatment in Kawasaki disease: a report from the Japanese Pediatric Interventional Cardiology Investigation Group. J Pediatr 137:181-186
2. Buellesfeld L, Gerckens U, Mueller R, Schmidt T, Grube E (2005) Polymer-based paclitaxel-eluting stent for treatment of chronic total occlusions of native coronaries: results of a Taxus CTO registry. Catheter Cardiovasc Interv 66:173-177
3. Colombo A, Drzewiecki J, Banning A, et al. TAXUS II Study Group (2003) Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel eluting stents for coronary artery lesion. Circulation 108:788-794
4. Grube E, Sütsch G, Lim VY, et al. (2006) High-frequency mechanical vibration to recanalize chronic total occlusions after failure to cross with conventional guidewires. J Invasive Cardiol 18:85-91
5. Ishii M, Ueno T, Akagi T, et al. (2001) Research Committee of Ministry of Health, Labour and Welfare-"Study of treatment and long-term management in Kawasaki disease." Guidelines for catheter intervention in coronary artery lesion in Kawasaki disease. Pediatr Int 43: 558-562
6. Ishii M, Ueno T, Ikeda H, et al. (2002) Sequential follow-up results of catheter intervention for coronary artery lesions after Kawasaki disease: quantitative coronary artery angiography and intravascular ultrasound imaging study. Circulation 105:3004-3010
7. Kato H, Sugimura T, Akagi T, et al. (1996) Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 94:1379-1385
8. Kitamura S (2004) Advances in Kawasaki disease bypass surgery for coronary artery obstructions. Prog Pediatr Cardiol 19:167-177
9. Lapierre C, Dahdah NS, Guerin R, Fournier A, Miró J, Duret J-S (2002) Significance of coronary artery calcification in Kawasaki disease. 88th annual meeting, Radiology Society of North America, Chicago, IL, USA, December 2002. Radiology Suppl 225:134
10. Li SS, Cheng BC, Lee SH (2005) Giant coronary aneurysm formation after sirolimus-eluting stent implantation in Kawasaki disease. Circulation 112:e105-e107
11. Melzi G, Cosgrave J, Biondi-Zoccai GL, et al. (2006) A novel approach to chronic total occlusions: the CROSSER system. Catheter Cardiovasc Interv 68:29-35
12. Migliorini A, Moschi G, Vergara R, et al. (2006) Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion. Catheter Cardiovasc Interv 67:344-348
13. Morice MC, Serruys PW, Sousa JE, et al. (2002) RAVEL Study Group. A randomized comparison of a sirolimus eluting stent with a standard stent for coronary revascularization. N Engl J Med 346:1773-1780
14. Newburger JW, Takahashi M, Gerber MA, et al. (2004) Diagnosis, treatment, and long-term management of Kawasaki disease. A statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association Endorsed by the American Academy of Pediatrics. Circulation 10:2747-2771
15. Tanaka N, Naoe S, Masuda H, Veno T (1986) Pathological study of sequelae of Kawasaki disease MCLS: with special reference to the heart and coronary arterial lesions. Acta Pathol Jpn 36:1513-1527
16. Tsuda E, Kamiya T, Ono Y, et al. (2005) Incidence of stenotic lesions predicted by acute changes in coronary arterial diameter during Kawasaki disease. Pediatr Cardiol 26:73-79
17. Tsuda E, Kitamura S, and the Cooperative Study Group of Japan (2004) National survey of coronary artery bypass grafting for coronary stenosis caused by Kawasaki disease in Japan. Circulation 110(Suppl 1):II61-II66